Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Phelps · SciRah

Researcher profile · Semantic Scholar

M. Phelps

Share profile

M. Phelps — researcher profile on SciRah

h-index: 40
Works: 229
Citations: 6,904

Most-cited papers

Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
Xiao-Hua Zhu, Mohamed S. Badawi, Steven M. Pomeroy, Dhruvitkumar S. Sutaria +9 more
2017Journal of Extracellular Vesicles518 citations Open access
Semantic Scholar
The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research
Saumya Das, K. Ansel, M. Bitzer, X. Breakefield +139 more
2019Cell196 citations Open access
Semantic Scholar
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study
R. Molokie, D. Lavelle, Michel Gowhari, M. Pacini +20 more
2017PLoS Medicine135 citations Open access
Semantic Scholar
ACHIEVING THE PROMISE OF THERAPEUTIC EXTRACELLULAR VESICLES: THE DEVIL IS IN DETAILS OF THERAPEUTIC LOADING
Dhruvitkumar S. Sutaria, Mohamed S. Badawi, M. Phelps, Thomas D. Schmittgen
2017Pharmaceutical Research128 citations Open access
Semantic Scholar
Discovery of Anticancer Agents of Diverse Natural Origin
L. Aldrich, Joanna E. Burdette, E. C. D. de Blanco, C. Coss +15 more
2022Journal of Natural Products112 citations Open access
Semantic Scholar
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and are Non-toxic up to High Doses in vivo
C. Lucas, Patrick D. Halley, Amjad A Chowdury, Bonnie K. Harrington +7 more
2022Small100 citations Open access
Semantic Scholar
PRMT5 as a druggable target for glioblastoma therapy
Y. Banasavadi-Siddegowda, Alessandra M. Welker, Min An, Xiaozhi Yang +11 more
2018Neuro-Oncology99 citations Open access
Semantic Scholar
Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery
Dhruvitkumar S. Sutaria, Jin-Mai Jiang, Ola A. Elgamal, Steven M. Pomeroy +8 more
2017Journal of Extracellular Vesicles86 citations Open access
Semantic Scholar
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration
J. Markowitz, Jiang Wang, Zachary C. Vangundy, J. You +13 more
2017Scientific Reports85 citations Open access
Semantic Scholar
Approaches to handling missing or “problematic” pharmacology data: Pharmacokinetics
Donald J. Irby, Mustafa E. Ibrahim, Anees M. Dauki, Mohamed A. Badawi +6 more
2021CPT: Pharmacometrics & Systems Pharmacology66 citations Open access
Semantic Scholar
Phase 2 Study of Ibrutinib in Classic and Variant Hairy Cell Leukemia.
K. Rogers, L. Andritsos, Wei Lai, Eric M. McLaughlin +20 more
2021Blood63 citations Open access
Semantic Scholar
SUV39H1 represses the expression of cytotoxic T-lymphocyte effector genes to promote colon tumor immune evasion
Chun-Wan Lu, Da-Feng Yang, John D. Klement, Kyu Oh +13 more
2019Cancer immunology research57 citations Open access
Semantic Scholar
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas
D. Sborov, A. Canella, E. Hade, X. Mo +17 more
2017Leukemia and Lymphoma57 citations Open access
Semantic Scholar
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yi-Zhen Guo, Lai Wei, Sandip H. Patel, G. Lopez +18 more
2022Clinical Lung Cancer46 citations Open access
Semantic Scholar
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer
R. Jain, C. Coss, P. Whooley, M. Phelps +1 more
2020Current Oncology Reports41 citations Open access
Semantic Scholar
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in CLL mouse model.
Chi-Ling Chiang, Swagata Goswami, Frank W. Frissora, Zhiliang Xie +13 more
2019Blood38 citations Open access
Semantic Scholar
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
Jae Yoon Jeon, Qiu-Hong Zhao, D. Buelow, M. Phelps +11 more
2019Investigational new drugs37 citations Open access
Semantic Scholar
Associations of high-dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial
Yu Kyoung Cho, D. Sborov, M. Lamprecht, Ju-Nan Li +12 more
2017Clinical pharmacology and therapy35 citations Open access
Semantic Scholar
Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
M. Phelps, C. Coss, Hongyan Wang, Matthew S. Cook
2016eLife35 citations Open access
Semantic Scholar
CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128
Mohamed S. Badawi, Jihye Kim, Anees M. Dauki, Dhruvitkumar S. Sutaria +9 more
2018OncoTarget34 citations Open access
Semantic Scholar
Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab
Kyeongmin Kim, M. Phelps
2023Clinical Pharmacokinetics33 citations Open access
Semantic Scholar
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer
S. Sardesai, Mohamed S. Badawi, E. Mrózek, Evan Morgan +16 more
2020Investigational new drugs32 citations Open access
Semantic Scholar
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia
Swagata Goswami, Rajeswaran Mani, J. Nunes, Chi-Ling Chiang +25 more
2021Blood31 citations Open access
Semantic Scholar
Cachectic Cancer Patients: Immune to Check-point Inhibitor Therapy?
C. Coss, S. Clinton, M. Phelps
2018Clinical Cancer Research30 citations Open access
Semantic Scholar
Discovery of Anticancer Agents of Diverse Natural Origin
A. Kinghorn, E. C. D. de Blanco, D. Lucas, H. L. Rakotondraibe +13 more
2016Anticancer Research29 citations Open access
Semantic Scholar
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
Sophia G. Liva, Yu-Chou Tseng, Anees M. Dauki, Michael G. Sovic +12 more
2020EMBO Molecular Medicine26 citations Open access
Semantic Scholar
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma
J. Maly, B. Christian, Xiao-Hua Zhu, Lai Wei +8 more
2017Clinical Lymphoma, Myeloma & Leukemia26 citations Open access
Semantic Scholar
A Phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies
K. Collier, Hugo E. Valencia, H. Newton, E. Hade +14 more
2021Cancer Chemotherapy and Pharmacology21 citations Open access
Semantic Scholar
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans
A. Castillo, T. Vu, Sophia G. Liva, Min Chen +14 more
2021JCSM Rapid Communications20 citations Open access
Semantic Scholar
In vitro immunotoxicity assessment of culture-derived extracellular vesicles in human monocytes
L. Rosas, Ola A. Elgamal, X. Mo, M. Phelps +2 more
2016Journal of Immunotoxicology19 citations Open access
Semantic Scholar
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer.
F. Backes, Lai Wei, Min Chen, Kasey Hill +11 more
2021Gynecologic Oncology18 citations
Semantic Scholar
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents
Hao Cheng, Zhiliang Xie, W. Jones, X. Wei +11 more
2016AAPS Journal18 citations Open access
Semantic Scholar
Phase I study of AR-42 and decitabine in acute myeloid leukemia
Sophia G. Liva, C. Coss, Jiang Wang, W. Blum +9 more
2020Leukemia and Lymphoma17 citations Open access
Semantic Scholar
Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant
Yu Kyoung Cho, Donald J. Irby, Ju-Nan Li, D. Sborov +10 more
2018CPT: Pharmacometrics & Systems Pharmacology17 citations Open access
Semantic Scholar
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
Peter Y. Yu, Heather L. Gardner, Ryan D. Roberts, H. Cam +13 more
2017PLoS ONE17 citations Open access
Semantic Scholar
A Phase I Trial of the Intravenous Hsp90 Inhibitor alvespimycin (17-DMAG) in Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
K. Maddocks, E. Hertlein, Timothy L Chen, Amy J. Wagner +6 more
2016Leukemia and Lymphoma17 citations Open access
Semantic Scholar
Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies
J. H. Hughes, M. Phelps, R. Upton, Stephanie E. Reuter +8 more
2019British Journal of Clinical Pharmacology15 citations Open access
Semantic Scholar
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399
R. Gentzler, Liza C. Villaruz, J. Rhee, B. Horton +10 more
2023The Oncologist14 citations Open access
Semantic Scholar
Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer
M. Issa, Joy Tang, Janet Guo, C. Coss +5 more
2022Expert Review of Anticancer Therapy12 citations Open access
Semantic Scholar
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks
T. H. Helms, R. Mullins, J. Thomas-Ahner, S. Kulp +9 more
2021Scientific Reports12 citations Open access
Semantic Scholar
Optimising time samples for determining area under the curve of pharmacokinetic data using non‐compartmental analysis
J. H. Hughes, R. Upton, Stephanie E. Reuter, M. Phelps +1 more
2019The Journal of pharmacy and pharmacology12 citations
Semantic Scholar
A Single Nucleotide Polymorphism in SLC7A5 Was Associated With Clinical Response in Multiple Myeloma Patients
M. Poi, Ju-Nan Li, Jasmine A. Johnson, Yu Kyoung Cho +3 more
2018Anticancer Research12 citations Open access
Semantic Scholar
Pharmacokinetics of intra-articular betamethasone sodium phosphate and betamethasone acetate and endogenous hydrocortisone suppression in exercising horses.
M. Menéndez, M. Phelps, A. Bertone
2016Journal of Veterinary Pharmacology and Therapeutics12 citations
Semantic Scholar
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer
N. Williams, Dionisia Quiroga, Courtney Johnson, A. Brufsky +17 more
2023Therapeutic Advances in Medical Oncology11 citations Open access
Semantic Scholar
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia
Bhavana Bhatnagar, Qiu-Hong Zhao, Alice S. Mims, S. Vasu +13 more
2023Leukemia and Lymphoma11 citations
Semantic Scholar
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer
Justin Thomas, Molly A. Torok, Kriti Agrawal, Timothy Pfau +17 more
2021International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
XRCC1‐mediated DNA repair is associated with progression‐free survival of multiple myeloma patients after autologous stem cell transplant
Avinash K. Persaud, Ju-Nan Li, Jasmine A. Johnson, Nathan D. Seligson +7 more
2019Molecular Carcinogenesis10 citations
Semantic Scholar
Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice
J. H. Hughes, R. Upton, Stephanie E. Reuter, Darlene M. Rozewski +2 more
2019Cancer Chemotherapy and Pharmacology8 citations Open access
Semantic Scholar
Letter to the Editor: Exposure-response or clearance-response relationship in immune checkpoint therapy?-A comment on 'correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer' by Basak et al.
Mohamed S. Badawi, C. Coss, M. Phelps
2019European Journal of Cancer8 citations
Semantic Scholar
NK Cell–Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin are Enhanced by Cytokines
A. C. Jaime-Ramirez, Elizabeth L. McMichael, S. Kondadasula, Cassandra C. Skinner +25 more
2016Cancer immunology research8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Coss×18
Invite
C. Coss — researcher profile on SciRah
Zhiliang Xie×8
Invite
Zhiliang Xie — researcher profile on SciRah
Mohamed S. Badawi×7
Invite
Mohamed S. Badawi — researcher profile on SciRah
J. Byrd×7
Invite
J. Byrd — researcher profile on SciRah

×7

Invite

S. Kulp — researcher profile on SciRah

Invite

Ming J. Poi — researcher profile on SciRah

C. Hofmeister×7

Invite

C. Hofmeister — researcher profile on SciRah

Invite

X. Mo — researcher profile on SciRah

Thomas D. Schmittgen×6

Invite

Thomas D. Schmittgen — researcher profile on SciRah

Invite

D. Sborov — researcher profile on SciRah

Anees M. Dauki×5

Invite

Anees M. Dauki — researcher profile on SciRah

Invite

D. Owen — researcher profile on SciRah